12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Adamis, Colby preclinical data

In a mouse model of pancreatic cancer, APC-300 significantly reduced tumor growth vs. controls (p<0.01). Furthermore, in human pancreatic adenocarcinoma cells, APC-300 significantly...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >